Preclinical Research

(Image: Getty/kishore kumar)

5 predictions for AI in 2019

By Melissa Fassbender

While several companies touted the potential of AI to disrupt the drug development industry in 2018, what practical applications can the industry expect next year?

(Image: PPD)

PPD adds biologics testing to GMP lineup in Ireland

By Melissa Fassbender

PPD is adding nearly 6,000 square feet of new lab space – and about 20 employees – dedicated to gene and cell therapy analytical testing at its site in Athlone, Ireland.

(Image: Getty/NicoElNino)

New AI tech reduces research bottlenecks

By Maggie Lynch

The new technology, Pattern to Knowledge (P2K), reduces “bottlenecks” in drug research by examining bio-sequences in a shorter time frame.

(Image: Getty/luchschen)

Quanterix expands biomarker tech to oncology research

By Melissa Fassbender

Quanterix is expanding its biomarker technology platform to oncology with the launch of a new test bed for up to 10-plex assays, which will enable drug developers to expedite clinical trials, says CEO.

Follow us

Products

View more

Webinars